Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Rep ; 7(1): 12352, 2017 09 27.
Artículo en Inglés | MEDLINE | ID: mdl-28955044

RESUMEN

Cell penetrating peptide derived from human eosinophil cationic protein (CPPecp) is a 10-amino-acid peptide containing a core heparan sulfate (HS)-binding motif of human eosinophil cationic protein (ECP). It binds and penetrates bronchial epithelial cells without cytotoxic effects. Here we investigated airway-protective effects of CPPecp in BEAS-2B cell line and mite-induced airway allergic inflammation in BALB/c mice. In BEAS-2B cell, CPPecp decreases ECP-induced eotaxin mRNA expression. CPPecp also decreases eotaxin secretion and p-STAT6 activation induced by ECP, as well as by IL-4. In vivo studies showed CPPecp decreased mite-induced airway inflammation in terms of eosinophil and neutrophil count in broncho-alveolar lavage fluid, peri-bronchiolar and alveolar pathology scores, cytokine production in lung protein extract including interleukin (IL)-5, IL-13, IL-17A/F, eotaxin; and pause enhancement from methacholine stimulation. CPPecp treated groups also showed lower serum mite-specific IgE level. In this study, we have demonstrated the in vitro and in vivo anti-asthma effects of CPPecp.


Asunto(s)
Antiasmáticos/farmacología , Asma/tratamiento farmacológico , Péptidos de Penetración Celular/farmacología , Proteína Catiónica del Eosinófilo/química , Mucosa Respiratoria/efectos de los fármacos , Alérgenos/inmunología , Animales , Antiasmáticos/uso terapéutico , Antígenos Dermatofagoides/inmunología , Asma/inmunología , Asma/patología , Bronquios/citología , Bronquios/efectos de los fármacos , Bronquios/inmunología , Línea Celular , Péptidos de Penetración Celular/química , Péptidos de Penetración Celular/uso terapéutico , Citocinas/inmunología , Citocinas/metabolismo , Evaluación Preclínica de Medicamentos , Eosinófilos/inmunología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/inmunología , Humanos , Masculino , Ratones , Ratones Endogámicos BALB C , Neutrófilos/inmunología , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacología , Proteínas Recombinantes/uso terapéutico , Mucosa Respiratoria/citología , Mucosa Respiratoria/inmunología , Resultado del Tratamiento
2.
Rheumatol Int ; 32(6): 1809-11, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21533912

RESUMEN

We report a rare case of diffuse systemic sclerosis (SSc) evolving into diffuse SSc/systemic lupus erythematosus (SLE) overlap syndrome. A 15-year-old boy was diagnosed as diffuse SSc with initial presentations of Raynaud's phenomenon and skin tightening. He underwent Chinese herbal treatment and clinical symptoms deteriorated in the following 3 years. On admission to our ward, serositis with pleural effusion, severe pulmonary fibrosis with moderate pulmonary hypertension, swallowing difficulty, and polyarthritis were observed. Autoantibody profiles revealed concurrence of anti-double-stranded DNA, anti-Smith, anti-topoisomerase I, and anti-ribonucleoprotein antibodies. The patient fulfills the criteria for both diffuse SSc and SLE. After drainage for pleural effusion accompanied by oral prednisolone and sildenafil, there were improvement of respiratory distress, swallowing difficulty, and pulmonary hypertension. In conclusion, connective tissue diseases may overlap with each other during the disease course. Serial follow-up for clinical symptoms as well as serological changes is recommended.


Asunto(s)
Lupus Eritematoso Sistémico/complicaciones , Esclerodermia Difusa/complicaciones , Adolescente , Antihipertensivos/uso terapéutico , Artritis/etiología , Autoanticuerpos/sangre , Biomarcadores/sangre , Trastornos de Deglución/etiología , Progresión de la Enfermedad , Drenaje , Medicamentos Herbarios Chinos/uso terapéutico , Glucocorticoides/uso terapéutico , Humanos , Hipertensión Pulmonar/etiología , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/terapia , Masculino , Piperazinas/uso terapéutico , Derrame Pleural/etiología , Prednisolona/uso terapéutico , Fibrosis Pulmonar/etiología , Purinas/uso terapéutico , Enfermedad de Raynaud/etiología , Esclerodermia Difusa/diagnóstico , Esclerodermia Difusa/inmunología , Esclerodermia Difusa/terapia , Serositis/etiología , Citrato de Sildenafil , Sulfonas/uso terapéutico , Resultado del Tratamiento
3.
J Microbiol Immunol Infect ; 42(6): 457-63, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20422129

RESUMEN

BACKGROUND AND PURPOSE: In addition to being an allergen, the trypsin activity of dust mite extract also destroys the tight junctions of bronchial epithelium. Such damage can lead to airway leakage, which increases airway exposure to allergens, irritants, and other pathogens. Dioscorin, the storage protein of yam, demonstrates anti-trypsin activity, as well as other potential anti-inflammatory effects. This study investigated the protective role of dioscorin for tight junctions. METHODS: The immunofluorescence stains of zonula occludens (ZO-1), E-cadherin (EC) and desmoplakin (DP) proteins were compared. A cultured A549 cell line was used as a control and A549 cells were incubated with mite extract 100 mg/mL for 16 h, with or without dioscorin 100 mg/mL pretreatment for 8 h and with dioscorin 100 mg/mL alone for 16 h. Western blot was performed to detect changes in ZO-1, EC, and DP in the treated A549 cell lines. RESULTS: Loss of tight junction protein expression (ZO-1, EC, DP) was demonstrated after 16-h mite extract incubation. The defect could be restored if cells were pretreated with dioscorin for 8 h. In addition, dioscorin did not cause damage to the A549 cell lines in terms of cell survival or morphology. Western blot showed no change in the amount of tight junction protein under various conditions. CONCLUSION: Dioscorin is a potential protector of airway damage caused by mite extract.


Asunto(s)
Proteínas de Plantas/uso terapéutico , Pyroglyphidae , Mucosa Respiratoria/parasitología , Uniones Estrechas/efectos de los fármacos , Animales , Western Blotting , Cadherinas/biosíntesis , Línea Celular , Desmoplaquinas/biosíntesis , Técnica del Anticuerpo Fluorescente , Humanos , Proteínas de la Membrana/biosíntesis , Microscopía Fluorescente , Fosfoproteínas/biosíntesis , Proteínas de Plantas/farmacología , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/inmunología , Uniones Estrechas/metabolismo , Proteína de la Zonula Occludens-1
4.
Pediatr Nephrol ; 21(4): 577-9, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16520953

RESUMEN

Aristolochic acid-associated nephropathy (AAN) has been identified as a separate entity of progressive tubulo-interstitial nephropathy. Its characteristic pathological findings, including hypocellular interstitial fibrosis, intimal thickening of interlobular and afferent arterioles with glomeruli sparing or mild sclerosis, have been identified. Many cases of AAN in adults have been reported in Taiwan as well as throughout the world, but it has seldom been described in children. We report on a 10-year-old boy who presented with severe anemia, Fanconi's syndrome, and progressive renal failure. Renal biopsy revealed typical findings of AAN. Aristolochic acids I and II were identified from a Chinese herb mixture ingested by the boy. AAN was diagnosed after other etiologies had been excluded. The case demonstrates the hazards of Chinese herbs with regard to children's health in Taiwan and suggests that more attention should be paid to this issue.


Asunto(s)
Ácidos Aristolóquicos/efectos adversos , Medicamentos Herbarios Chinos/efectos adversos , Síndrome de Fanconi/inducido químicamente , Riñón/patología , Nefritis Intersticial/inducido químicamente , Insuficiencia Renal/inducido químicamente , Niño , Fibrosis , Humanos , Masculino
5.
J Microbiol Immunol Infect ; 36(1): 56-60, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12741735

RESUMEN

This retrospective study examined the characteristics of 338 pediatric patients presenting with a first episode of symptomatic urinary tract infection at Taichung Veterans General Hospital from November 1996 to December 2001. Escherichia coli was the most common pathogen (72.5%), followed by Proteus mirabilis (8.3%), Enterococcus (5.6%), and Klebsiella pneumoniae (4.7%). They were more susceptible to first-generation cephalosporin in comparison with other first-line antimicrobial agents such as trimethoprim/sulfamethoxazole, ampicillin, and gentamicin. Two hundred and eighty-seven (84.9%) of the 338 patients were divided into 3 groups according to the type of antibiotic treatment received, and the susceptibility rate and the averaged day of defervescence after effective antibiotic therapy were compared among the groups. Group 1 consisted of those patients treated with cefazolin or cephalexin alone (95%, 2.1 days); Group 2, cefazolin plus gentamicin (88.9%, 2.8 days); and Group 3, ampicillin plus gentamicin (76.1%, 2.3 days). A total of 38 (13.2%) cases from the 3 antibiotic groups did not respond to empiric antibiotics. For non-susceptible infections, when the antibiotic regimen was switched from cefazolin plus gentamicin to ampicillin alone, only 4 (20%) strains became susceptible, compared with 10 strains (62.5%) becoming susceptible after switching from ampicillin plus gentamicin to cefazolin alone (p < 0.01). The results indicated that first-generation cephalosporin alone is an appropriate treatment for pediatric cases of community-acquired urinary tract infection and suggest that antimicrobial combinations should be reserved for serious or critical cases.


Asunto(s)
Antibacterianos/uso terapéutico , Quimioterapia Combinada/uso terapéutico , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Adolescente , Antibacterianos/farmacología , Niño , Preescolar , Escherichia coli/efectos de los fármacos , Femenino , Humanos , Lactante , Recién Nacido , Klebsiella pneumoniae/efectos de los fármacos , Masculino , Pruebas de Sensibilidad Microbiana , Proteus mirabilis/efectos de los fármacos , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA